The latest brain, head and neck cancer news
Two targeted therapies, dabrafenib (taflinar) plus trametinib (mekinst), significantly increased the overall response rate compared to…
Immunotherapy has had limited success so far against glioblastoma, the most common and aggressive form…
Scientists at the University of Michigan Rogel Cancer Center, USA, were optimistic when they identified a small molecule…
A novel combination of two experimental cancer immunotherapy agents along with an immune checkpoint blocker…
Most head and neck cancer patients treated with radiation therapy develop long-term treatment-related dry mouth, or xerostomia,…
New adaptive radiotherapy technique for head and neck cancer can deliver a more robust treatment…
Glioblastomas (GBMs) are highly aggressive cancerous tumours of the brain and spinal cord. Brain cancers…
More and more mutations clutter up our DNA as we age. Mostly, these don’t cause…
About one-fifth of often deadly head and neck cancers harbour genetic mutations in a pathway…
Results from an interim analysis of the phase III RATIONALE 306 study, showed anti-PD-1 immune…